Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03297489 · ClinicalTrials.gov registry record · Early Phase 1
Intravital Microscopy in Evaluating Patients With Primary Peritoneal, Fallopian Tube, or Stage IA-IV Ovarian Cancer
A Early Phase 1 study, sponsored by Roswell Park Cancer Institute.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 19
- Enrollment target
NCT03297489 is a Early Phase 1 study that has completed, run by Roswell Park Cancer Institute. The registered enrollment target is 19 participants.
The verdict
NCT03297489, a Early Phase 1 study, has completed, sponsored by Roswell Park Cancer Institute.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 19 participants
- Enrollment target
Study Summary
This pilot clinical trial studies how well intravital microscopy works in evaluating patients with primary peritoneal, fallopian tube, or stage IA-IV ovarian cancer. Intravital microscopic evaluation of tumor blood vessels, blood flow, immune cell interactions, and drug uptake may be eventually visualized and may lead to valuable prognostic information.
Interventions
- OTHER Laboratory Biomarker Analysis
- DRUG Fluorescein Sodium Injection
- PROCEDURE Diagnostic Microscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2017-11-06 |
| Est. Completion | 2021-02-15 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03297489
The ClinicalTrials.gov registry entry for NCT03297489 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Roswell Park Cancer Institute, which has 365 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Laboratory Biomarker Analysis is the first listed.
NCT03297489 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03297489 about?
NCT03297489 is a clinical study titled "Intravital Microscopy in Evaluating Patients With Primary Peritoneal, Fallopian Tube, or Stage IA-IV Ovarian Cancer". This pilot clinical trial studies how well intravital microscopy works in evaluating patients with primary peritoneal, fallopian tube, or stage IA-IV ovarian cancer. Intravital microscopic evaluation of tumor blood vessels, blood flow, immune cell interactions, and drug uptake may be eventually visu...
What is the current status of trial NCT03297489?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 19 participants. The study started on 2017-11-06. Estimated completion is 2021-02-15.
What interventions are being tested in trial NCT03297489?
The interventions under investigation include: Laboratory Biomarker Analysis (OTHER), Fluorescein Sodium Injection (DRUG), Diagnostic Microscopy (PROCEDURE).
Who is sponsoring clinical trial NCT03297489?
This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.